India  
 
NewsR.in

1 in 3 Covaxin recipients hit by adverse events: Study

IndiaTimes Thursday, 16 May 2024
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual abnormalities in 5% of women. AstraZeneca's vaccine technology controversy and Covishield's development by the Serum Institute of India are notable. The study reported viral upper respiratory tract infections in adolescents and adults.
0
shares		ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions


Related news from verified sources

ICMR slams BHU's Covaxin study, says it wasn't part of it

 Indian Council of Medical Research criticizes a recently-published study on Covaxin's safety analysis for poor methodology. The study wrongly acknowledges ICMR....
IndiaTimes

Over 30% Covaxin takers suffered from health issues after 1 year: Report

 A study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI)....
IndiaTimes